Skip to main content
Back

Microbial Mechanisms of Pathogenicity: Study Notes

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Microbial Mechanisms of Pathogenicity

Introduction

This chapter explores the strategies used by microorganisms to cause disease in hosts, focusing on the mechanisms of pathogenicity, portals of entry and exit, and the molecular and cellular interactions that determine the outcome of infection.

Pathogenicity and Virulence

Definitions and Concepts

  • Pathogenicity: The ability of a microorganism to cause disease.

  • Virulence: The degree of pathogenicity; a measure of the severity of disease caused by a microbe.

Portals of Entry

Major Portals of Entry

  • Mucous membranes: Includes the respiratory tract (most common), digestive canal, genitourinary system, and conjunctiva. Pathogens enter via inhalation, ingestion, or sexual contact.

  • Skin: Generally impenetrable unless compromised; entry may occur through hair follicles or sweat gland ducts.

  • Parenteral route: Direct deposition into tissues beneath the skin or mucous membranes, such as through punctures, injections, bites, cuts, or surgery.

Most pathogens have a preferred portal of entry that is critical for their ability to cause disease.

Overview of microbial mechanisms of pathogenicity, including portals of entry, evasion of host defenses, damage to host cells, and portals of exit

Numbers of Invading Microbes

ID50 and LD50

  • ID50: Infectious dose for 50% of a sample population; measures the virulence of a microbe.

  • LD50: Lethal dose for 50% of a sample population; measures the potency of a toxin.

Example: Bacillus anthracis has different ID50 values depending on the portal of entry (skin: 10–50 endospores; inhalation: 10,000–20,000; ingestion: 250,000–1,000,000).

Botulinum toxin is extremely potent, with an LD50 of 0.03 ng/kg.

Adherence to Host Cells

Mechanisms of Adherence

  • Pathogens attach to host tissues via adherence (adhesion).

  • Adhesins (ligands) on the pathogen bind to specific receptors on host cells.

  • Examples:

    • Glycocalyx of Streptococcus mutans enables adherence to teeth.

    • Fimbriae of Actinomyces adhere to the glycocalyx of S. mutans.

    • Viral spikes (e.g., SARS-CoV-2) bind to ACE2 receptors on host cells.

Mechanisms of adherence: pathogen ligands binding to host cell receptors, E. coli on bladder cells, bacteria adhering to skin

Penetration or Evasion of Host Defenses

Capsules and Cell Wall Components

  • Capsules: Glycocalyx layers that impair phagocytosis (e.g., Streptococcus pneumoniae, Bacillus anthracis).

  • M protein: Resists phagocytosis (Streptococcus pyogenes).

  • Opa protein: Facilitates attachment to host cells (Neisseria gonorrhoeae).

  • Mycolic acid: Waxy lipid in cell wall resists digestion (Mycobacterium tuberculosis).

Enzymes as Virulence Factors

  • Coagulases: Coagulate fibrinogen to form clots.

  • Kinases: Digest fibrin clots.

  • Hyaluronidase: Digests hyaluronic acid, aiding tissue penetration.

  • Collagenase: Breaks down collagen.

  • IgA proteases: Destroy IgA antibodies.

Antigenic Variation

  • Pathogens alter their surface antigens to evade immune detection (e.g., influenza virus, Neisseria gonorrhoeae, Trypanosoma brucei gambiense).

Penetration into Host Cells

  • Invasins: Bacterial surface proteins that rearrange host actin filaments, causing membrane ruffling and bacterial engulfment (e.g., Shigella, Listeria).

  • Bacteria may use actin to move between cells.

  • Some survive inside phagocytes by escaping the phagosome, preventing lysosomal fusion, or tolerating low pH.

Salmonella entering intestinal epithelial cells via membrane ruffling

Biofilms

  • Biofilms resist antibiotics and disinfectants, are involved in 65% of infections, and shield bacteria from phagocytosis via extracellular polymeric substances (EPS).

How Bacterial Pathogens Damage Host Cells

Using the Host’s Nutrients: Siderophores

  • Pathogens secrete siderophores to bind iron more tightly than host proteins, facilitating iron uptake essential for bacterial growth.

Structure of enterobactin, a bacterial siderophore

Direct Damage

  • Pathogens disrupt host cell function, use host nutrients, produce waste products, and may cause cell rupture by multiplying inside cells.

Production of Toxins

  • Toxins: Poisonous substances produced by microorganisms, causing fever, cardiovascular issues, diarrhea, and shock.

  • Toxigenicity: Ability to produce toxins.

  • Toxemia: Presence of toxins in the blood.

  • Intoxications: Disease caused by toxins without microbial growth.

Exotoxins

  • Proteins secreted by bacteria, usually highly specific and potent.

  • Can be neutralized by antitoxins or inactivated as toxoids for vaccines.

Exotoxins: proteins produced inside bacteria and released outside the cell

Types of Exotoxins

  • A-B toxins: Consist of an active (A) and binding (B) component (e.g., diphtheria toxin).

  • Genotoxins: Damage DNA, potentially leading to cancer.

  • Membrane-disrupting toxins: Lyse host cells by disrupting membranes (e.g., leukocidins, hemolysins, streptolysins).

  • Superantigens: Trigger excessive immune responses, causing fever, shock, and death.

Mechanism of action of an A-B exotoxin

Diseases Caused by Exotoxins

Disease

Bacterium

Type of Exotoxin

Mechanism

Botulism

Clostridium botulinum

A-B

Neurotoxin; prevents nerve impulse transmission; flaccid paralysis.

Tetanus

C. tetani

A-B

Neurotoxin; blocks muscle relaxation; uncontrollable contractions.

Diphtheria

Corynebacterium diphtheriae

A-B

Cytotoxin; inhibits protein synthesis.

Cholera

V. cholerae

A-B

Enterotoxin; causes diarrhea.

Anthrax

Bacillus anthracis

A-B

Shock and immune suppression.

Food poisoning

S. aureus

Superantigen

Enterotoxin; diarrhea.

Toxic shock syndrome

S. aureus

Superantigen

Shock, decreased blood volume.

Endotoxins

  • Lipid A portion of lipopolysaccharides (LPS) in the outer membrane of gram-negative bacteria.

  • Released during bacterial death or cell wall lysis.

  • Cause fever, shock, disseminated intravascular coagulation, and may weaken the blood-brain barrier.

Endotoxins: lipid portions of LPS released from gram-negative bacteria Endotoxins and the pyrogenic response: steps leading to fever

Limulus Amebocyte Lysate (LAL) Assay

  • Used to detect endotoxins; based on the clotting reaction of horseshoe crab blood in the presence of endotoxin.

Comparison of Exotoxins and Endotoxins

Property

Exotoxins

Endotoxins

Bacterial Source

Gram-positive and gram-negative

Gram-negative

Chemistry

Proteins (A-B structure)

Lipid A of LPS

Heat Stability

Unstable (destroyed at 60–80°C)

Stable (withstands 121°C)

Toxicity

High

Low

Fever-Producing

No

Yes

Immunology

Can be neutralized by antitoxin; toxoids for vaccines

Not easily neutralized; no effective toxoids

Lethal Dose

Small

Large

Representative Diseases

Tetanus, botulism, diphtheria

Typhoid fever, meningococcal meningitis

Plasmids, Lysogeny, and Pathogenicity

  • Plasmids: May carry genes for toxins, antibiotic resistance, and virulence factors.

  • Lysogenic conversion: Incorporation of a prophage can confer new properties, such as toxin production (e.g., diphtheria toxin).

Pathogenic Properties of Viruses

Mechanisms of Viral Pathogenicity

  • Viruses evade host defenses by intracellular location, using host cell surface molecules, attacking immune components, methylating RNA, and antigenic variation.

Cytopathic Effects (CPE)

  • Visible effects of viral infection on host cells; can be cytocidal (cell death) or noncytocidal (cell damage).

  • Examples:

    • Disruption of cell junctions

    • Cytokine storm induction

    • Inclusion body formation (e.g., Negri bodies in rabies)

    • Syncytium formation (fusion of cells)

    • Antigenic changes, chromosomal damage, loss of contact inhibition (cancer)

    • Interferon production

Cytopathic effects: inclusion bodies and syncytium formation Human fibroblasts transformed by Rous sarcoma virus

Interferons

  • Alpha and beta interferons are produced by infected cells to protect neighboring cells by inhibiting viral protein synthesis and inducing apoptosis.

  • Some viruses can evade interferon responses.

Pathogenic Properties of Fungi, Protozoa, Helminths, and Algae

Fungi

  • Produce toxic metabolic products, provoke allergic responses, and secrete proteases that modify host membranes.

  • Capsules (e.g., Cryptococcus neoformans) prevent phagocytosis.

  • Mycotoxins (e.g., aflatoxin, ergot alkaloids) can be carcinogenic or neurotoxic.

Protozoa

  • Cause symptoms by their presence and waste products.

  • Evade defenses by digesting cells, growing in phagocytes, and antigenic variation (e.g., Trypanosoma).

Helminths

  • Use host tissues for growth, produce large masses, and release waste products that cause symptoms.

Algae

  • Some produce neurotoxins (e.g., saxitoxin from Alexandrium), causing paralytic shellfish poisoning.

Portals of Exit

Major Portals of Exit

  • Respiratory tract: Coughing and sneezing

  • Gastrointestinal tract: Feces and saliva

  • Genitourinary tract: Urine and genital secretions

  • Skin

  • Blood: Via arthropod bites or contaminated needles

Portals of exit are generally the same as the portals of entry for a given microbe.

Pearson Logo

Study Prep